ACIU
AC Immune SA
NASDAQ · Healthcare · Biotechnology · CH
$2.44
+1.88%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 9.82x
- P/E 2028E
- 5.36x
- P/S forward
- 102.57x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.67x
- Price / sales
- 11.39x
- Price / cash flow
- -5.73x
Enterprise value
- Enterprise value
- $155.6M
- EV / sales
- 7.32x
- EV / EBITDA
- -3.07x
- EV / EBIT
- -2.90x
- Market cap
- $242.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026